Gilead Shines Some Light On Its Inflammation Ambitions

Part Of Ongoing Diversification Strategy

 
• By Mandy Jackson
  
Gilead announced a new deal and reworked an old deal in inflammation already this year (Shutterstock)

More from Strategy

More from Conferences